Article info
PDFCorrespondence
Presence of antiphospholipid antibodies in COVID-19: a case series study
- Correspondence to Dr Luis M Amezcua-Guerra, Departamento de Inmunología, Instituto Nacional de Cardiologia Ignacio Chavez, 14080 Tlalpan, Mexico; lmamezcuag{at}gmail.com
Citation
Presence of antiphospholipid antibodies in COVID-19: a case series study
Publication history
- Received May 23, 2020
- Accepted May 25, 2020
- First published August 4, 2020.
Online issue publication
January 08, 2022
Article Versions
- Previous version (8 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage